Jelliffe RW - Search Results

1

Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models.

Labaune JM, Bleyzac N, Maire P, Jelliffe RW, Boutroy MJ, Aulagner G, Putet G. Labaune JM, et al. Among authors: jelliffe rw. Biol Neonate. 2001 Aug;80(2):142-7. doi: 10.1159/000047133. Biol Neonate. 2001. PMID: 11509814

2

Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation.

Bleyzac N, Varnier V, Labaune JM, Corvaisier S, Maire P, Jelliffe RW, Putet G, Aulagner G. Bleyzac N, et al. Among authors: jelliffe rw. Eur J Clin Pharmacol. 2001 Sep;57(6-7):499-504. doi: 10.1007/s002280100355. Eur J Clin Pharmacol. 2001. PMID: 11699615 Clinical Trial.

3

Prediction of future serum concentrations with Bayesian fitted pharmacokinetic models: results with data collected by nurses versus trained pharmacy residents.

Charpiat B, Breant V, Pivot-Dumarest C, Maire P, Jelliffe R. Charpiat B, et al. Ther Drug Monit. 1994 Apr;16(2):166-73. doi: 10.1097/00007691-199404000-00010. Ther Drug Monit. 1994. PMID: 8009565

4

Diurnal changes in the pharmacokinetic behavior of amikacin.

Bleyzac N, Allard-Latour B, Laffont A, Mouret J, Jelliffe R, Maire P. Bleyzac N, et al. Ther Drug Monit. 2000 Jun;22(3):307-12. doi: 10.1097/00007691-200006000-00012. Ther Drug Monit. 2000. PMID: 10850398

5

Preliminary results of three methods for population pharmacokinetic analysis (NONMEM, NPML, NPEM) of amikacin in geriatric and general medicine patients.

Maire P, Barbaut X, Girard P, Mallet A, Jelliffe RW, Berod T. Maire P, et al. Among authors: jelliffe rw. Int J Biomed Comput. 1994 Jun;36(1-2):139-41. doi: 10.1016/0020-7101(94)90106-6. Int J Biomed Comput. 1994. PMID: 7927854 No abstract available.

6

[Individual variability of pharmacokinetic parameters of amikacin in the elderly: retrospective studies].

Vincent S, Maire PH, Bataillard T, Denjean E, Ducrozet P, Laffont A, Visent C, Jelliffe RW. Vincent S, et al. Among authors: jelliffe rw. Pathol Biol (Paris). 1996 Sep;44(7):667-74. Pathol Biol (Paris). 1996. PMID: 8977923 French.

7

Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens.

Bleyzac N, Souillet G, Magron P, Janoly A, Martin P, Bertrand Y, Galambrun C, Dai Q, Maire P, Jelliffe RW, Aulagner G. Bleyzac N, et al. Among authors: jelliffe rw. Bone Marrow Transplant. 2001 Oct;28(8):743-51. doi: 10.1038/sj.bmt.1703207. Bone Marrow Transplant. 2001. PMID: 11781625

8

Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors.

Martin P, Bleyzac N, Souillet G, Galambrun C, Bertrand Y, Maire PH, Jelliffe RW, Aulagner G. Martin P, et al. Among authors: jelliffe rw. Bone Marrow Transplant. 2003 Nov;32(9):881-7. doi: 10.1038/sj.bmt.1704239. Bone Marrow Transplant. 2003. PMID: 14561988 Clinical Trial.

9

Renal elimination of amikacin and the aging process.

Ducher M, Maire P, Cerutti C, Bourhis Y, Foltz F, Sorensen P, Jelliffe R, Fauvel JP. Ducher M, et al. Clin Pharmacokinet. 2001;40(12):947-53. doi: 10.2165/00003088-200140120-00004. Clin Pharmacokinet. 2001. PMID: 11735610

10

[Adaptive control of therapeutics using amikacin in very old patients: retrospective analysis of efficacy and toxicity].

Grillot M, Maire PH, Confesson MA, Cogoluenhes V, Pivot C, Druguet M, Courpron P, Jelliffe RW. Grillot M, et al. Among authors: jelliffe rw. Pathol Biol (Paris). 1994 Mar;42(3):247-53. Pathol Biol (Paris). 1994. PMID: 8090575 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters